A study published by Leimer and others in Cell October 6th 2021, highlighted the rediscovery of the antibiotic hygromycin A against Lyme’s disease. Lyme’s disease is on the rise. It is caused by the spirochete Borreliella burgdorferi and affects an...
The editorial published in Lancet Infectious Diseases October 14th 2021, reviews this issue. There has been widespread coverage in the media of Merck and Ridgeback’s interim results of their phase 2 trial of the antiviral molnupiravir. According to a press...
An article published by Stahlberg and Riek in Nature September 2021 establishes that high resolution structures of previously uncharacterised strains of tau fibril purified from the postmortem brains of individuals with various neurodegenerative diseases could be used...
A paper from America published by the CDC shows that people who have received a vaccine booster are reporting side effects which are similar to those after the second dose. The report relies on more than 12,500 submissions via V-safe, the CDC smartphone based...
An interesting paper published on 9th September 2021, in Nature Human Behaviour by Yang and others looked at the effect of remote working on collaboration amongst information workers. The COVID-19 pandemic caused a rapid shift to full time remote work for...
An interesting article published by Grzesiak and others in the Journal of the American Medical Association network open on September 29th 2021 looked at this issue. Currently, there exist no pre-symptomatic screening methods to identify individuals infected with...
